Tumor-Associated Raynaud's Phenomenon Exacerbated by Administration of Immune Checkpoint Inhibitors. Sumi T, Michimata H, Nagayama D, Koshino Y, et al. J Thorac Oncol 2022;17:1233-1234.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sumi T, Michimata H, Nagayama D, Koshino Y, et al. Tumor-Associated Raynaud's Phenomenon Exacerbated by Administration of Immune Checkpoint Inhibitors. J Thorac Oncol 2022;17:1233-1234.
PMID: 36192079